Get started
Live feed
NEWSReleasevia Quantisnow
Jaguar Health Inc. logo

Jaguar Health Reports First Quarter 2026 Financials

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for JAGX

Across the 30 sessions after earlier JAGX headlines, the stock closed higher 11 times and lower 19 times, with a median move of 7.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

JAGX close-to-close change in the session after earlier headlines
SessionEarlier headlineJAGXSPY
May 20, 2026Jaguar Health to Hold Investor Webcast May 26 Regarding Q1 2026 Financials & Corporate Updates; Jaguar CEO Lisa Conte Presenting May 28 at Lytham Partners Spring 2026 Investor Conference+9.4%+1.0%
May 19, 2026Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer-9.3%-0.7%
May 8, 2026Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule+0.7%+0.8%
May 6, 2026Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)-6.3%+1.4%
May 4, 2026Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health-51.4%-0.4%
Apr 29, 2026Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs-6.6%-0.0%

Keep researching JAGX

Quantisnow market dataNASDAQ
Jaguar Health Inc. logo
JAGX
Jaguar Health Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2015
Get push alerts for JAGX

Follow JAGX and get a push notification the moment its next story breaks.

Full JAGX profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JAGX (Jaguar Health Inc.) and more on Quantisnow.